Influence-Tools/republic-os
1
0
Fork 0
Code Issues Pull Requests Actions Packages Projects Releases Wiki Activity
Files
main
republic-os/legislation/us/states/va/2024/hb-342.md
T
Fabio 5a13be122b Legislation: batch E — CA TN VA VT WA WI WV WY 
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
2026-07-06 17:28:36 -04:00

8.9 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Naloxone or other opioid antagonists; possession by state agencies, guidelines for private employer. Naloxone or other opioid antagonists; possession and administration by state agencies. Requires state agencies to possess naloxone or other opioid antagonists used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose and permits employees of any state agency to possess and administer naloxone or other opioid antagonists. The bill also directs the Department of Health to post on its website informational resources relating to the use of naloxone and other opioid antagonists for opioid overdose reversal and prevention in public places. Finally, the bill directs the Department of Health to develop a plan for the procurement and distribution of naloxone or other opioid antagonists to each state agency and for the possession of naloxone or other opioid antagonists by each state agency and to report its progress in developing such plan to the Governor and the Chairmen of the House Committee on Health and Human Services and the Senate Committee on Education and Health by November 1, 2024. us/states/va Virginia General Assembly 2024 HB 342 Virginia HB 342 (2024)
bill
enacted
Patrick A. Hope
6 54 11 2024-01-05 2024-04-04 openstates ocd-bill/20de1ce6-dfe7-4fa4-8d36-2003899f8bf7 https://lis.virginia.gov/cgi-bin/legp604.exe?241+sum+HB342 6edf1383768a213ddf6fe54375a63968438d4c109b1b89a53010e826d437c242 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-va

Virginia HB 342 (2024) — Naloxone or other opioid antagonists; possession by state agencies, guidelines for private employer.

Naloxone or other opioid antagonists; possession and administration by state agencies. Requires state agencies to possess naloxone or other opioid antagonists used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose and permits employees of any state agency to possess and administer naloxone or other opioid antagonists. The bill also directs the Department of Health to post on its website informational resources relating to the use of naloxone and other opioid antagonists for opioid overdose reversal and prevention in public places. Finally, the bill directs the Department of Health to develop a plan for the procurement and distribution of naloxone or other opioid antagonists to each state agency and for the possession of naloxone or other opioid antagonists by each state agency and to report its progress in developing such plan to the Governor and the Chairmen of the House Committee on Health and Human Services and the Senate Committee on Education and Health by November 1, 2024.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. CHAP0440 (committee substitute) — source
  2. Committee substitute printed 24106801D-H1 (committee substitute) — source
  3. Committee substitute printed 24108846D-S1 (committee substitute) — source
  4. Conference substitute printed 24109115D-H2 (committee substitute) — source
  5. HB342ER (committee substitute) — source
  6. Prefiled and ordered printed; offered 01/10/24 24100674D (committee substitute) — source

Votes

  • Reported from Finance and Appropriations with substitute (15-Y 0-N) — 15–0 (pass) · upper
  • Reported from Education and Health (15-Y 0-N) — 15–0 (pass) · upper
  • Reported from Health and Human Services with substitute (22-Y 0-N) — 22–0 (pass) · lower
  • VOTE: Block Vote Passage (100-Y 0-N) — 99–0 (pass) · lower
  • VOTE: Adoption (95-Y 0-N) — 94–0 (pass) · lower
  • Senate insisted on substitute (40-Y 0-N) — 40–0 (pass) · upper
  • VOTE: REJECTED (0-Y 99-N) — 0–98 (fail) · lower
  • Subcommittee recommends reporting with substitute (8-Y 0-N) — 8–0 (pass) · lower
  • Constitutional reading dispensed (39-Y 0-N) — 39–0 (pass) · upper
  • Passed Senate with substitute (40-Y 0-N) — 40–0 (pass) · upper
  • Conference report agreed to by Senate (40-Y 0-N) — 40–0 (pass) · upper

Sponsors

  • Patrick A. Hope — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2024-01-05 Prefiled and ordered printed; offered 01/10/24 24100674D filing, introduction
  • 2024-01-05 Referred to Committee on Health and Human Services referral-committee
  • 2024-01-17 Assigned sub: Health referral-committee
  • 2024-01-23 Impact statement from DPB (HB342)
  • 2024-02-01 House subcommittee amendments and substitutes offered
  • 2024-02-01 Subcommittee recommends reporting with substitute (8-Y 0-N) substitution
  • 2024-02-01 Subcommittee recommends referring to Committee on Appropriations referral-committee
  • 2024-02-06 Reported from Health and Human Services with substitute (22-Y 0-N) committee-passage
  • 2024-02-06 Committee substitute printed 24106801D-H1 substitution
  • 2024-02-08 Read first time reading-1
  • 2024-02-09 Impact statement from DPB (HB342H1)
  • 2024-02-09 Read second time reading-2
  • 2024-02-09 Committee substitute agreed to 24106801D-H1 substitution
  • 2024-02-09 Engrossed by House - committee substitute HB342H1 substitution
  • 2024-02-12 Read third time and passed House BLOCK VOTE (100-Y 0-N) passage, reading-3
  • 2024-02-12 VOTE: Block Vote Passage (100-Y 0-N) passage
  • 2024-02-13 Constitutional reading dispensed
  • 2024-02-13 Referred to Committee on Education and Health referral-committee
  • 2024-02-21 Assigned Education and Health Sub: Health Professions referral-committee
  • 2024-02-29 Reported from Education and Health (15-Y 0-N) committee-passage
  • 2024-02-29 Rereferred to Finance and Appropriations referral-committee
  • 2024-03-04 Reported from Finance and Appropriations with substitute (15-Y 0-N) committee-passage
  • 2024-03-04 Committee substitute printed 24108846D-S1 substitution
  • 2024-03-05 Constitutional reading dispensed (39-Y 0-N)
  • 2024-03-05 Impact statement from DPB (HB342S1)
  • 2024-03-06 Read third time reading-3
  • 2024-03-06 Reading of substitute waived
  • 2024-03-06 Committee substitute agreed to 24108846D-S1 substitution
  • 2024-03-06 Engrossed by Senate - committee substitute HB342S1 substitution
  • 2024-03-06 Passed Senate with substitute (40-Y 0-N) passage
  • 2024-03-07 Senate substitute rejected by House 24108846D-S1 (0-Y 99-N)
  • 2024-03-07 VOTE: REJECTED (0-Y 99-N)
  • 2024-03-07 Senate insisted on substitute (40-Y 0-N) substitution
  • 2024-03-07 Senate requested conference committee referral-committee
  • 2024-03-07 House acceded to request
  • 2024-03-07 Conferees appointed by Senate
  • 2024-03-07 Senators: Favola, Aird, Head
  • 2024-03-07 Conferees appointed by House
  • 2024-03-07 Delegates: Hope, Shin, Higgins
  • 2024-03-08 Amended by conference committee
  • 2024-03-08 Conference substitute printed 24109115D-H2
  • 2024-03-08 Conference report agreed to by Senate (40-Y 0-N) committee-passage-favorable
  • 2024-03-08 Conference report agreed to by House (95-Y 0-N) committee-passage-favorable
  • 2024-03-08 VOTE: Adoption (95-Y 0-N)
  • 2024-03-08 Impact statement from DPB (HB342H2)
  • 2024-03-25 Enrolled enrolled
  • 2024-03-25 Bill text as passed House and Senate (HB342ER) passage
  • 2024-03-25 Signed by President passage
  • 2024-03-26 Signed by Speaker passage
  • 2024-03-27 Impact statement from DPB (HB342ER)
  • 2024-03-27 Enrolled Bill communicated to Governor on March 27, 2024 enrolled, executive-receipt
  • 2024-03-27 Governor's Action Deadline 11:59 p.m., April 8, 2024 executive-receipt
  • 2024-04-04 Approved by Governor-Chapter 440 (effective 7/1/24) executive-signature
  • 2024-04-04 Acts of Assembly Chapter text (CHAP0440)

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/20de1ce6-dfe7-4fa4-8d36-2003899f8bf7. Confidence: reported (aggregated from official Virginia legislature records).

Reference in New Issue View Git Blame Copy Permalink